Cytogenetic and molecular diagnostic testing associated with prenatal and postnatal birth defects

Stela Z Berisha1, Shashi Shetty1,2, Thomas W Prior1,2

  • 1Center for Human Genetics, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Insights

Genetic testing aids in diagnosing prenatal and early postnatal conditions, identifying causes of developmental issues and birth defects. Various advanced genetic techniques help pinpoint specific genetic variations for accurate diagnosis.

Area of Science:

  • Medical Genetics
  • Clinical Diagnostics

Background:

  • Genetic testing provides crucial insights for patients and clinicians facing complex prenatal and early postnatal medical issues.
  • It is instrumental in investigating conditions such as developmental delay, intellectual disability, congenital anomalies, and reproductive challenges.

Purpose of the Study:

  • To highlight the utility of genetic testing in diagnosing a wide spectrum of pediatric and prenatal conditions.
  • To review the application of diverse genetic diagnostic techniques in identifying the underlying causes of birth defects and other genetic disorders.

Main Methods:

  • Utilizes a range of diagnostic cytogenetic and molecular genetic techniques.
  • Includes conventional methods alongside state-of-the-art approaches like chromosomal microarrays and next-generation sequencing.

Main Results:

  • Genetic testing effectively identifies or confirms diagnoses for numerous conditions, including developmental delays, intellectual disabilities, and congenital malformations.
  • These methods can rule out specific single-gene or chromosomal abnormalities, providing definitive diagnostic answers.

Conclusions:

  • Genetic testing is a valuable tool in prenatal and postnatal diagnostics, offering clarity for complex medical problems.
  • The complementary nature of various genetic techniques enhances the ability to detect causative genetic variations, particularly for birth defects.

Related Concept Videos

Karyotyping01:17

Karyotyping

Overview
67.9K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.5K